Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
GB00BM9XQ619
Wed, 20.11.2024       Vidac Pharma Holding Plc

Company Name: Vidac Pharma Holding Plc ISIN: GB00BM9XQ619   Reason for the research: Update Report Recommendation: Buy from: 20.11.2024 Target price: EUR 4.90 (unchanged) Target price on sight of: 36 months Last rating change: - Analyst: Peter Thilo Hasler Vidac Pharma has been granted a broad and exclusive patent by the United [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 26.12.2024, Calendar Week 52, 361st day of the year, 5 days remaining until EoY.